Oscar Health, Inc. (OSCR) Stock Dips While Market Gains: Key Facts

Oscar Health (OSCR) closed at $29.90, down 3.05% in the most recent trading session, underperforming the S&P 500's 0.2% gain. Despite recent monthly gains of 1.68%, the stock faces headwinds from the Finance sector's 4.84% decline. However, analysts project strong earnings growth with EPS expected at -$0.11 (up 79.25% YoY) and revenue of $4.72 billion (up 58.14% YoY). The company holds a Zacks Rank #1 (Strong Buy) rating with a Forward P/E of 16.82, trading at a premium to its industry average of 9.52.